Pancreatic cancer is 'always non-resectable'

Area of Science:

• Oncology
• Surgical Oncology

Background:

• Pancreatic cancer exhibits aggressive biology, leading to rapid dissemination and poor outcomes.
• Late diagnosis is common due to the tumor's 'silent' nature, rendering interventions ineffective.

Discussion:

• Few pancreatic tumors are resectable, and even small ones may have poor prognostic factors.
• Preoperative assessments of resectability are often inaccurate, with many tumors found non-resectable during surgery.
• Elderly or chronically ill patients are poor surgical candidates, limiting treatment options and tolerance to surgical stress.

Key Insights:

• Pancreatic cancer's aggressive nature significantly impacts patient survival.
• The majority of pancreatic cancers are treated non-surgically due to late diagnosis and patient comorbidities.
• Specialized, high-volume centers are recommended for the limited number of resectable pancreatic cancer cases.

Outlook:

• Improving early detection methods for pancreatic cancer is critical.
• Advancements in neoadjuvant therapies may improve resectability rates for pancreatic tumors.
• Enhanced patient selection and perioperative care are needed for surgical candidates.